VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH MM 2018 | MRD and disease eradication in myeloma

We spoke to Jesús San Miguel, MD, PhD, of the University of Navarra, Pamplona, Spain, to discuss the importance of measurable residual disease (MRD) in the eradication of multiple myeloma (MM). This interview was recorded at the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter